Heart failure is a complex clinical syndrome affecting around 70 million individuals globally. It has a prevalence of 2% in ...
Risk for HF hospitalization and all-cause mortality are reduced in patients with HFrEF that have digitoxin added to guideline-directed therapy.
San Francisco, CA, Dec. 18, 2019 (GLOBE NEWSWIRE) -- Eko, a digital health company applying artificial intelligence (AI) in the fight against heart disease, today announced the U.S. Food and Drug ...
Heart failure (HF) imposes a large and growing burden on the population, with a prevalence that is projected to increase to more than 8 million adults by 2030. The high risk of morbidity and mortality ...
In a recent meta-analysis which included individual-patient data from five randomized trials, beta-blocker therapy did not ...
PUMPING FOR LIFE: Ejection fraction is a measure of how much blood your heart is pumping. With each heartbeat, the heart contracts and relaxes. As it contracts, the left and right ventricles eject ...